Human pathology · 2026
Elastica-van Gieson-Based Periarterial/Perivenous Invasion and Periductal Invasion as Differential Predictors of Lymph Node Metastasis After Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Special Type.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mashiba Chikara, Shioya Akihiro, Oyama Takeru, Han Jia, Kumagai Motona, Shimasaki Miyako, Takata Takanobu, Haba Yusuke, Morioka Emi, Inokuchi Masafumi, Yamada Sohsuke
Аннотация
BACKGROUND/OBJECTIVES: Periarterial/perivenous invasion (periA/V) on Elastica-van Gieson (EVG) staining is a highly sensitive histological marker of lymph node metastasis (LNM) in invasive breast carcinoma of no special type (IBC-NST) without neoadjuvant chemotherapy (NAC), but its value after NAC remains unclear. We evaluated periA/V and periductal invasion (periD) as LNM predictors according to histological therapeutic effect.
METHODS: We retrospectively analyzed 108 patients with residual IBC-NST after NAC, stratified into good-response (n = 44) and poor-response (n = 64) groups. LNM was defined as N0(i+), N1mi, or N1-3. Associations were assessed by Fisher's exact test and conventional or Firth logistic regression. Multivariate models included pathological T category and, in the overall cohort, histological therapeutic effect.
RESULTS: LNM was present in 56 (51.9%) patients. In the overall cohort, periD (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.26-10.60) and ypT2-4 (OR, 2.97; 95% CI, 1.02-8.64) were independently associated with LNM, whereas periA/V and histological therapeutic effect were not. In good responders, periD showed a borderline multivariate association (OR, 5.75; 95% CI, 0.955-60.675; p = 0.056), with high specificity (96.3%) and positive predictive value (83.3%). In poor responders, periA/V remained independently associated with LNM (OR, 6.67; 95% CI, 1.14-69.97; p = 0.034), with high sensitivity (97.4%) and negative predictive value (90.0%).
CONCLUSIONS: Associations of EVG-based parameters with LNM differed by histological therapeutic effect: periD showed a borderline association in good responders, whereas periA/V remained independently associated in poor responders, suggesting complementary roles in post-NAC risk stratification.
METHODS: We retrospectively analyzed 108 patients with residual IBC-NST after NAC, stratified into good-response (n = 44) and poor-response (n = 64) groups. LNM was defined as N0(i+), N1mi, or N1-3. Associations were assessed by Fisher's exact test and conventional or Firth logistic regression. Multivariate models included pathological T category and, in the overall cohort, histological therapeutic effect.
RESULTS: LNM was present in 56 (51.9%) patients. In the overall cohort, periD (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.26-10.60) and ypT2-4 (OR, 2.97; 95% CI, 1.02-8.64) were independently associated with LNM, whereas periA/V and histological therapeutic effect were not. In good responders, periD showed a borderline multivariate association (OR, 5.75; 95% CI, 0.955-60.675; p = 0.056), with high specificity (96.3%) and positive predictive value (83.3%). In poor responders, periA/V remained independently associated with LNM (OR, 6.67; 95% CI, 1.14-69.97; p = 0.034), with high sensitivity (97.4%) and negative predictive value (90.0%).
CONCLUSIONS: Associations of EVG-based parameters with LNM differed by histological therapeutic effect: periD showed a borderline association in good responders, whereas periA/V remained independently associated in poor responders, suggesting complementary roles in post-NAC risk stratification.